INITIAL PRESENTATION
The patient, a 16-day-old male infant, was born to nonconsanguineous white parents, of European descent, at 37 weeks of gestation, via elective caesarian section, weighing 2900 g at birth. At presentation, the infant had copious amounts of watery diarrhea (>10 bowel movements daily) with mucus, but no blood. In addition, he had persistent, nonbilious, nonbloody emesis with feeds, and weight loss of 20% from birth.
Initial evaluation and physical examination were remarkable for dehydration, failure to thrive and lack of dysmorphic or syndromic features. Newborn screening, imaging studies, stool testing, infectious, immunologic, allergic, and extensive laboratory workup did not reveal an etiology for the infant's symptoms. As part of the diagnostic workup, an upper endoscopy and flexible sigmoidoscopy, with biopsies, were performed at 3 weeks of age. Gross findings were unremarkable, but histologic findings revealed acute esophagitis, gastritis, and duodenitis, as well as inflammatory eosinophilic infiltrates in the lamina propria of the colon, suggestive of an infectious or allergic etiology (Fig. 1) . As the infant's clinical condition did not improve with time or with an exclusive elemental formula diet, additional biopsies were obtained at 2 months of age, revealing villous atrophy in the duodenum, with coalescence of the surface epithelium into characteristic tufts in both the duodenum and the colon (Fig. 2) .
DIAGNOSTIC CONFIRMATION
The diagnosis of TE was established based on the infant's clinical course and histological findings. To further support the diagnosis, immunohistochemical staining for EpCAM was performed, with absence of EpCAM confirmed in the duodenum and colon; electron microscopy demonstrated significant elongation of desmosomes in both tissues (Fig. 2C) . Ultimately, genetic studies were undertaken to corroborate the diagnosis and to explore a possible disease genotype-phenotype relation in TE.
For genetic testing, exome sequencing was performed under a research protocol, as previously described (4) . Sequence analysis revealed a known pathogenic splicing mutation at position À1 of exon 4 in EPCAM (c.426-1G>A, Fig. 3A ) (3) . The mutation was present in 48% of the 50 reads covering the nucleotide. Familial testing revealed that the mutation was inherited paternally. A second, novel nonsense mutation of maternal origin was identified, confirming compound heterozygosity in EPCAM, consistent with a molecular diagnosis of TE. The second mutation (c.265C>T) is predicted to result in an introduction of a premature stop codon at amino acid 89 (p.Gln89X) (Fig. 3B) . The mutation was found in 54% of 61 sequencing reads covering the position. It is previously unreported and absent from the exome variant server (http://evs.gs. washington. edu/EVS/), and other commonly used genomic databases (ie, 1000 genomes, Center for Pediatric Genomic Medicine) (4). Both mutations were confirmed clinically by capillary sequencing.
CLINICAL COURSE
The patient is now 2 years old and has had clinical improvement in symptoms, growth, and development with initiation of longterm, outpatient, total parenteral nutrition (TPN). He presently receives 80% of his calories from TPN; the remainder, from continuous gastric feeds of elemental formula. He has had stable, mild, total parenteral nutrition-related cholestasis and continues to require systemic budesonide therapy for persistent eosinophilic enterocolitis. Attempts to wean budesonide have resulted in histologically documented recurrence of intestinal eosinophilic infiltrates, and predominantly upper tract gastrointestinal symptoms (ie, vomiting/retching).
CONCLUSIONS
Certain TE phenotypes (ie, Maltese) appear to be associated with more favorable clinical outcomes, including successful weaning of TPN (5) . Recent published reports, however, have failed to establish a clear disease histology-phenotype relation (6) . As more causative mutations in EPCAM are described, it will become possible to evaluate whether a disease genotype-phenotype relation exists for TE.
Herein, we describe a novel nonsense mutation in EPCAM (p.Gln89X), associated with the clinical and immunohistochemical diagnosis of TE. This finding provides new insight into the disease pathogenesis of TE and raises the possibility for a disease genotype-phenotype relation. It is plausible that these causative mutations could help explain the unusual feature of eosinophilic enterocolitis in our patient because they were associated with absent EpCAM expression. Although, in theory, permeability in the intestinal mucosa of patients with TE could predispose to eosinophilic infiltrates, this histologic finding is not commonly reported in the TE literature (5). Alternatively, there may be a genetic component to duodenal versus colonic manifestations of TE, as not all patients 
Total count: 50 A: 24 (43%, 12+, 12-) C: 0 develop tufts in both the small and the large intestine. n very-low-birth-weight (VLBW) infants with intestinal perforation, partial resection of the perforated bowel combined with enterostomy is one of the most common surgical procedures. A high-output stoma after ileostomy or jejunostomy, however, can lead to dehydration, excessive sodium loss, electrolyte imbalance, cholestasis, and delayed weight gain because of malnutrition (1-3). Recycling bowel contents from the oral to anal side of the enterostomy is one option for preventing these adverse effects of a high-output stoma. In addition, Schafer et al (1) reported that continuous extracorporeal stool transport can prevent cholestasis in premature infants and neonates with a stoma because it restores enterohepatic circulation (4) At our center, we have performed recycling of bowel contents in low-birth-weight infants with a high stoma. In the present case series study, the benefit of recycling bowel contents in VLBW infants with creation of a high stoma for small intestinal perforation was assessed by comparison between infants with and without recycling.
Between 2003 and 2013, 8 neonates with intestinal perforation underwent establishment of an ileostomy at our center. Their demographic data are shown in Table 1 . We started recycling of bowel contents in 2009. Four of the 8 neonates were treated after 2009 and received recycling of stool (recycling (þ) group). Three neonates were treated before 2009 and stool recycling was not done (cases 1-3 of the recycling (À) group). One neonate was treated in 2009 and recycling was initiated, but was soon abandoned because stool from the oral opening of the stoma was almost solid (case 4 of the recycling (À) group). We excluded patients with necrotizing enterocolitis and small bowel perforation secondary to systemic infections such as disseminated Mucor infection because their general condition is often poor owing to these severe underlying diseases. Recycling of stool was started after postoperative commencement of oral feeding following establishment of the ileostomy. If problems with the stoma were encountered, it was closed when the infant was stable and the body weight was >2000 g. If prolapse of the oral stoma opening occurred when the infant was stable and weight gain was consistent, the stoma was, however, closed even if the body weight was <2000 g. Statistical analysis was performed with the unpaired Student t test (for serum albumin, hemoglobin, hematocrit, serum iron, mean cell volume, mean cell hemoglobin, mean cell hemoglobin concentration) or the MannWhitney U test (duration of stoma survival, duration of total parental nutrition, duration of central venous line use, and body weight), with P < 0.05 being considered to indicate statistical significance.
There was no difference of birth weight between the recycling (þ) group and the recycling (À) group (881 AE 163 vs 798 AE 177 g [mean AE SD], P ¼ 0.514), and there was no difference in the timing of establishing the ileostomy (6.3 AE 5.6 vs 7.0 AE 2.9 days after birth, P ¼ 0.820). All of the infants in both groups were fed their mother's breast milk, and if this was insufficient, formula was added after the start of oral feeding. There was no significant difference in the duration of total parenteral nutrition (8.8 AE 14.9 vs 11.3 AE 5.9 days, P ¼ 0.457) or the duration of central venous line use (26.5 AE 6.8 vs 31.5 AE 11.3 days, P ¼ 0.661). Severe cholestasis was not observed in either group. The maximum serum level of direct bilirubin ranged from 1.0 to 3.3 mg/dL in the recycling (þ) group and from 0.1 to 1.0 mg/dL in the recycling (À) group (1.9 AE 0.99 vs 0.68 AE 0.40, P ¼ 0.062). Elevation of direct bilirubin was transient and it declined to <1 mg/dL before stoma closure in all of the infants.
